Mundo: Oncopeptides phase 3 LIGHTHOUSE study further confirms clinical benefit of melflufen (2)

Mundo: Oncopeptides phase 3 LIGHTHOUSE study further confirms clinical benefit of melflufen (2)

Mundo: Oncopeptides phase 3 LIGHTHOUSE study further confirms clinical benefit of melflufen (1)

Mundo: Oncopeptides phase 3 LIGHTHOUSE study further confirms clinical benefit of melflufen (1)

Mundo: ASSA ABLOY :Quarterly Report Q3 2022

Mundo: ASSA ABLOY :Quarterly Report Q3 2022

Mundo: Aker Horizons ASA: Invitation to Presentation of Third-Quarter Results 2022

Mundo: Aker Horizons ASA: Invitation to Presentation of Third-Quarter Results 2022

Mundo: Elkem – Third quarter 2022: Strong results, despite weaker market conditions (2)

Mundo: Elkem - Third quarter 2022: Strong results, despite weaker market conditions (2)

Mundo: Elkem – Third quarter 2022: Strong results, despite weaker market conditions (1)

Mundo: Elkem - Third quarter 2022: Strong results, despite weaker market conditions (1)

Mundo: Noreco Announce Third Quarter 2022 Results: Operational and Financial Outperformance

Mundo: Noreco Announce Third Quarter 2022 Results: Operational and Financial Outperformance

Mundo: Arabia Saudita convocará al sector minero mundial en el segundo Foro de Minerales del Futuro

Mundo: Arabia Saudita convocará al sector minero mundial en el segundo Foro de Minerales del Futuro

Mundo: SUSE ofrece una solución nativa en la nube Kubernetes y sistemas operativos en el edge (2)

Mundo: SUSE ofrece una solución nativa en la nube Kubernetes y sistemas operativos en el edge…

Mundo: SUSE ofrece una solución nativa en la nube Kubernetes y sistemas operativos en el edge (1)

Mundo: SUSE ofrece una solución nativa en la nube Kubernetes y sistemas operativos en el edge…